Table 1.
Characteristic | Total (N = 882) | No Malariaa (n = 701) | Malariaa (n = 181) |
---|---|---|---|
Antiretroviral randomization | |||
Maternal antiretroviral | 294 (33) | 235 (34) | 59 (33) |
Infant nevirapine | 297 (34) | 239 (34) | 58 (32) |
Enhanced control | 291 (33) | 227 (32) | 64 (35) |
Nutritional randomization | |||
No supplement | 449 (51) | 357 (51) | 92 (51) |
Received supplement | 433 (49) | 344 (49) | 89 (49) |
Mothersb | |||
Age, y | |||
15–25 | 436 (50) | 355 (51) | 81 (45) |
26–35 | 404 (46) | 312 (45) | 92 (51) |
36–45 | 39 (4) | 33 (5) | 6 (3) |
Parity | |||
0 | 133 (15) | 109 (16) | 24 (13) |
≥1 | 748 (85) | 591 (84) | 57 (87) |
Education | |||
Primary school only | 567 (64) | 441 (63) | 126 (70) |
More than primary school | 314 (36) | 260 (37) | 54 (30) |
Infantsb | |||
Sex | |||
Female | 443 (50) | 350 (50) | 93 (51) |
Male | 439 (50) | 351 (50) | 88 (49) |
Birth weight, kg | |||
<2.5 | 66 (8) | 56 (8) | 10 (6) |
≥2.5 | 814 (93) | 643 (92) | 171 (94) |
Hemoglobin, g/dL | |||
<13.4 | 54 (6) | 44 (6) | 10 (6) |
≥13.4 | 828 (94) | 657 (94) | 171 (94) |
Neutropenia, ×103 cells/µL | |||
<1 | 23 (3) | 18 (3) | 5 (3) |
≥1 | 859 (97) | 683 (97) | 176 (97) |
Data are presented as No. (%).
a Malaria defined as clinical or polymerase chain reaction–positive malaria.
b Maternal age missing for 3 mother–infant pairs, parity and maternal education missing for 1 mother–infant pair, infant birthweight missing for 2 infants. Percentages may not add to 100 due to rounding.